Investing Profile

Mason Freeman

InvestorVC
Vice President, Translational Medicine at Novartis
5amventures.comBoston, Massachusetts
Photo of Mason Freeman, Novartis Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Harvard University Network
899 CONNECTIONS
Novartis Network
82 CONNECTIONS
Harvard Medical School Network
77 CONNECTIONS
Massachusetts General Hospital Network
43 CONNECTIONS
cb
$100K - $5.0M
$1.5M
1
$750M
CompanyStageDateRound SizeTotal Raised
Crinetics Pharmaceuticals
Series ANov 2015$40M
$100M
Co-investors: Tom Woiwode (Versant Ventures), Jack Nielsen (Vivo Capital)
Professor of Medicine Harvard Medical SchoolPresent
Physician Massachusetts General HospitalPresent
Vice President, Translational Medicine NovartisPresent
University of California, San Francisco - School of Medicine M.D. Medicine
Harvard University A.B. History & Literature
Sign in with Google →
Sign in with Google →